Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Pharmatek, a contract development and manufacturing organization supporting the pharmaceutical industry, has made a substantial investment into its spray drying capabilities.
read more
SGS has introduced comprehensive drug compatibility study testing at its Shanghai laboratory in China. This new service, for the analysis of potential extractable and leachable contamination within pharmaceutical products, harmonizes services offered...
read more
SynCo Bio Partners, a contract manufacturer of biopharmaceuticals, has announced that one of its customers, PaxVax, has received FDA approval for Vaxchora™, a single-dose oral, live attenuated cholera vaccine, indicated for use in adults 18 to 64 ...
read more
G&W Laboratories has announced the appointment of Jay Galeotato the position of President and Chief Operating Officer. Mr. Galeota joins G&W following a 28-year career at Merck, where he was most recently Chief Strategy & Business Development Officer...
read more
Hovione recently held the official groundbreaking for the expansion of its New Jersey Facility in East Windsor, NJ.
read more
Cryoport has announced the launch of its bio-storage offering. The new offering is the result of a clear demand from Cryoport customers to complement its cryogenic logistics solutions with advanced storage and fulfillment capabilities.
read more
Frontage Laboratories has announced that they have completed a GLP validation of the Simoa HD-1 Analyzer and software along with the interface to Watson LIMS. Data will be generated, processed and stored in a secure environment meeting the compliance...
read more
IMS Health and Reltio have announced that IMS Health is offering Reltio Cloud with its Nexxus™ Commercial Application Suite and IMS One™ platform. Through the alliance, IMS Health will offer life sciences organizations new options for fast, scalable ...
read more
Veristat, a full service Clinical Research Organization (CRO), announced that it has strengthened its statistical consulting and adaptive design expertise with the appointment of Mark Chang, PhD to the newly created position of Senior Vice President ...
read more
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has announced research showing many pharmaceutical and clinical research organizations (CROs) support the use ...
read more
Averica Discovery Services Inc., an analytical development Contract Research Organization (CRO) based in the Greater Boston area, and Dalton Pharma Services, a contract provider of integrated chemistry, drug development, and manufacturing services ...
read more
Wolfe Laboratories has announced that Frank Tagliaferri, Ph.D., has been appointed Vice President, Pharmaceutical Development, effective immediately.
read more
AMRI has announced that its Buffalo, N.Y. site has been selected to participate as a Dedicated Chemical Biology Consortium (CBC) Center for the Experimental Therapeutics (NExT) Program, centered at the Frederick National Laboratory for Cancer ...
read more
PAREXEL International Corporation, a global biopharmaceutical services provider, has signed a services agreement with Pfizer Inc. Under the terms of this agreement, PAREXEL will continue to provide global clinical research and development services to...
read more
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has signed a three-year agreement with Pfizer Inc.
read more